During the marketing of loratadine, alopecia and anaphylaxis have been reported rarely. As with other sympathomimetic amines, CNS stimulation, muscular weakness, tightness in the chest and syncope may also be encountered. In the event of overdosage, treatment, which should be started immediately, is symptomatic and supportive. Other signs and symptoms may be euphoria, excitement, tachycardia, palpitations, thirst, perspiration, nausea, dizziness, tinnitus, ataxia, blurred vision and hypertension or hypotension. In large doses sympathomimetics may give rise to giddiness, headache, nausea, vomiting, sweating, thirst, tachycardia, precordial pain, plapitations, difficulty in micturition, muscular weakness and tenseness, anxiety, restlessness and insomnia.
Many patients can present a toxic psychosis with delusions and hallucinations.
Some may develop cardiac arrhythmias, circulatory collapse, convulsions, coma and respiratory failure. The patient should be induced to vomit, even if emesis has occurred spontaneously. Pharmacologically-induced vomiting by the administration of ipecac syrup is a preferred method. However, vomiting should not be induced in patients with impaired consciousness. The action of ipecac is facilitated by physical activity and by the administration of 240 to 360 milliters of water.